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Purpose:

To validate quantitative imaging techniques used to detect
and measure steatosis with magnetic resonance (MR) imaging in an ob/ob mouse model of hepatic steatosis.

Materials and
Methods:

The internal research animal and resource center approved this study. Twenty-eight male ob/ob mice in progressively increasing age groups underwent imaging and
were subsequently sacrificed. Six ob/+ mice served as
control animals. Fat fraction imaging was performed with
a chemical shift–based water-fat separation method. The
following three methods of conventional fat quantification
were compared with imaging: lipid extraction and qualitative and quantitative histologic analysis. Fat fraction images were reconstructed with single- and multiple-peak
spectral models of fat and with and without correction
for T2* effects. Fat fraction measurements obtained with
the different reconstruction methods were compared with
the three methods of fat quantification, and linear regression analysis and two-sided and two-sample t tests were
performed.

Results:

Lipid extraction and qualitative and quantitative histologic
analysis were highly correlated with the results of fat
fraction imaging (r2 = 0.92, 0.87, 0.82, respectively). No
significant differences were found between imaging measurements and lipid extraction (P = .06) or quantitative
histologic (P = .07) measurements when multiple peaks of
fat and T2* correction were included in image reconstruction. Reconstructions in which T2* correction, accurate
spectral modeling, or both were excluded yielded lower
agreement when compared with the results yielded by
other techniques. Imaging measurements correlated particularly well with histologic grades in mice with low fat
fractions (intercept, 21.0% 61.2 [standard deviation]).

Conclusion:

MR imaging can be used to accurately quantify fat in vivo
in an animal model of hepatic steatosis and may serve as
a quantitative biomarker of hepatic steatosis.
q
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onalcoholic fatty liver disease
(NAFLD) is the most common
cause of chronic liver disease (1),
and its prevalence parallels the current
epidemic of obesity and diabetes (2).
NAFLD is closely linked with diseases
of the metabolic syndrome, such as
type II diabetes mellitus, obesity, and
hyperlipidemia, and it has a strong association with insulin resistance (2,3).
The hallmark of NAFLD is fatty infiltration of hepatocytes (hepatic steatosis).
However, in many patients, steatosis
can progress to inflammation and fibrosis (1,2,4,5) and eventually cirrhosis, which is a predisposing risk factor
for hepatocellular carcinoma and liver
failure (4–7). Methods for early detection and assessment of NAFLD through
quantitative measurement of steatosis
are needed for earlier intervention to
avoid progression to cirrhosis.
The earliest biomarker of NAFLD
is hepatic steatosis, which currently
requires biopsy for definitive diagnosis. Biopsy has an inherent limitation of
high sampling variability due to the heterogeneous nature of steatosis (8). Although currently the standard of care,
biopsy is costly, may put the patient at
risk for potentially severe complications
(9), and—as a result—is not suitable
for repeated evaluation (2,9). Thus,
a noninvasive alternative to biopsy is
needed.
Magnetic resonance (MR) imaging
has the potential to address the important unmet need of rapid, safe, noninvasive quantitative in vivo fat detection
and assessment over the entire liver.
Current techniques for MR fat quantification include chemical shift–based
methods, such as spectroscopy (10),

Advances in Knowledge
n Quantification of fat with MR
imaging correlates strongly with
qualitative and quantitative histologic assessment and quantitative
lipid extraction over a wide range
of steatosis in vivo.
n Correction for T2* decay and
accurate spectral modeling are
essential for accurate fat quantification in the liver.
120
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gradient-echo in-phase and out-of-phase
imaging (11–13), and three-point Dixon
techniques (14–17).
For MR imaging to be considered
an accurate quantitative fat assessment
method, several existing confounding
factors must be addressed. These factors include T2* decay, the complex
nuclear MR spectrum of fat, and T1
and noise biases. The presence of an
increased level of iron in the liver is
a common finding in patients with
NAFLD (2,18,19); this shortens T2* and
degrades the fat quantification abilities
of many MR imaging methods. Second,
most current chemical shift–based fatwater separation techniques model fat as
a single peak at 2210 Hz relative to water
(at 1.5 T) (11,14,20–22), although several other spectral peaks arising from
fat exist (23). These multiple spectral
peaks must be considered in the fat signal model to achieve accurate quantification of the total fat signal. In addition,
differences in T1 values between water
and fat can lead to overestimation of fat
when rapid T1-weighted sequences are
used (11,24), making the measured fat
fraction T1 dependent (T1 bias). Use of
magnitude images causes apparent nonzero fat fractions in low-signal-intensity
areas (25).
One approach used to quantify fat is
the chemical shift–based MR technique
known as iterative decomposition of
water and fat with echo asymmetry and
least-squares estimation (IDEAL). The
IDEAL water-fat decomposition method
enables robust separation of fat and
water (16,21,26), and modifications allow

Implications for Patient Care
n Quantification of fat with MR
imaging may provide an accurate
noninvasive alternative to biopsy,
which is the current standard in
the detection and assessment of
steatosis.
n Noninvasive assessment of steatosis with chemical shift–based
MR imaging is feasible in an
animal model and is a potential
clinical biomarker in the early
detection and quantitative grading of hepatic steatosis.

additional measurement and correction
of T2* (27). This method can also be
used to address T1- and noise-related
biases, as well as to provide accurate
spectral modeling (20,28,29). Although
validation has already been performed
for correction of T1 (21,25) and noise
biases (20), correction methods for
T2* decay and accurate spectral modeling that consider multiple spectral fat
peaks have not been validated in vivo.
In this study, we performed reconstructions with and without combinations
of T2* correction and modeling of the
multiple peaks of fat to validate these
correction factors.
Although MR imaging fat quantification methods have been validated
in phantoms, in vivo validation is still
required because phantoms may not accurately simulate fatty accumulation in
tissue. The use of animal experiments
is advantageous because the animal’s
liver can be used for comparison with
other reference standards. For example,
extensive histologic assessment and
biochemical total lipid extraction, both
of which are highly invasive and/or destructive techniques, are not suitable for
use in human studies because patients
cannot undergo repeated biopsy. The
ob/ob mouse is an excellent model of
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hepatic steatosis because of its expression of many NAFLD traits (30). These
mice are genetically leptin deficient,
which causes excessive overeating and
development of obesity, steatosis, steatohepatitis, and diabetes, among other
symptoms of NAFLD (31,32).
The purpose of this study was to
validate quantitative imaging techniques
used to detect and measure steatosis
with MR imaging in an ob/ob mouse
model of hepatic steatosis.

Hines et al

phosphate-buffered saline, and their
livers were immediately excised. All
animal preparation was performed by
one individual (C.D.G.H., 4 years of
experience with small animal handling).
The body temperature of the mice may
decrease when they are sedated. This
decrease in temperature can cause a
shift in the proton resonance frequency
of water (Df ), as shown in the following
equation:
f

Materials and Methods
This study was a collaborative effort
between the University of Wisconsin
and GE Healthcare; however, there was
no direct financial support from GE
Healthcare for this study. In addition,
all experiments were performed at the
University of Wisconsin. The authors
who were not employees of GE Healthcare had control of data and information that might have presented a conflict of interest.

Animal Preparation
Animal research protocols for this
prospective study were approved by our
institutional research animal resource
center. Twenty-eight 5-week-old (at
the start of the study) male ob/ob mice
(Harlan-Sprague-Dawley, Indianapolis,
Ind) were housed in pairs with food
and water ad libitum. All mice were
5 weeks old at the start of the study.
Obese mice (ob/ob) were divided into
four groups, imaged, and subsequently
sacrificed at 5 (n = 6), 7 (n = 10), 9
(n = 6), and 13 (n = 6) weeks of age because the severity of steatosis and obesity increases throughout this age range
(31,33). Six 5-week-old lean littermate control mice (ob/+) were examined and sacrificed at 9 weeks of age;
mice with this genotype do not exhibit
obesity, hepatic steatosis, or signs of
NAFLD.
Prior to imaging, mice were anesthetized with an intraperitoneal injection
of pentobarbital (40 mg per kilogram
of body weight) (Ovation Pharmaceuticals, Deerfield, Ill). Immediately after
imaging, mice were euthanized with
CO2, their tissues were perfused with
Radiology: Volume 254: Number 1—January 2010
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B0 T ,

where a is equal to 0.01 ppm/°C according to Taylor et al (34), g/2p is
equal to 42.58 MHz/T and is the gyromagnetic ratio of protons, and B0 is the
strength of the main magnetic field. In
the worst case, a 10°C decrease in body
temperature (DT) would cause a shift
in the water resonance of less than
13 Hz at 3.0 T. This shift is small
compared with a shift of 420 Hz, and
simulations indicate that this error
would have negligible effects on waterfat separation with the IDEAL technique. In addition, a 10°C decrease in
body temperature would likely be fatal
to the mice. Given that all mice survived anesthesia, it is highly unlikely
that body temperature confounded any
of the fat fraction measurements obtained in this study.

Imaging Sequence and Parameters
Imaging was performed with a 3.0-T
clinical imager (Signa TwinSpeed HDx;
GE Healthcare, Waukesha, Wis) with a
custom-built quadrature birdcage coil
sized for rodents (C.D.G.H., 4 years of
imaging experience). The coil had an
inner diameter of 8 cm and a length of
11.5 cm. Data were collected by using
a three-dimensional spoiled gradientecho sequence and reconstructed with
a T2*-corrected IDEAL algorithm (27).
Imaging parameters for the T2*corrected IDEAL sequence were as
follows: flip angle, 5°; first echo time,
2.1 msec; repetition time, 30 msec;
field of view, 12 3 7 cm; matrix, 256
3 154; bandwidth, 6100 kHz; one
signal acquired; 28 sections; and section thickness, 0.8 mm. A total of 15

radiology.rsna.org

echoes were acquired, with three interleaved five-echo time/repetition time
acquisitions and the first echo time at
2.1 msec. Each repetition time had an
echo spacing of 3.7 msec, and each
repetition time was shifted by 1.2 msec,
making the effective echo spacing for
the equally spaced echoes 1.2 msec.
Total imaging time was 7 minutes 24
seconds, and true spatial resolution was
0.5 3 0.5 3 0.8 mm. Sedation of mice
with pentobarbital led to no perceptible
breathing artifacts.

Image Reconstruction
Several modifications have been made
to the IDEAL algorithm to correct for
the confounding factors of noise and
T1 biases, T2* decay, and the spectral
complexity of fat. The modified T2*corrected IDEAL algorithm uses a magnitude discrimination method to calculate fat fraction without noise bias (20),
and in this study, we used a low flip
angle (5°) to minimize T1 bias (20,24).
The IDEAL technique also uses a region-growing algorithm for field map
estimation, rather than phase unwrapping, to prevent fat-water swaps on reconstructed images (35).
The T2*-corrected IDEAL algorithm accounts and corrects for T2*
decay by decoupling the effects of T2*
from those induced by the chemical
shift of fat by using a modified signal
model with a complex field map (27),
which enables simultaneous estimation of water, fat, and T2*. In addition, a multipeak IDEAL reconstruction method that accounts for multiple
spectral peaks of fat has been developed recently but not validated in vivo
(28,29). Bydder et al (24) also reported
a related approach with phantom validation. The multipeak reconstruction
uses a self-calibrated fat signal evolution model that accounts for multiple spectral peak amplitudes in the
acquired data for use in the modified
IDEAL algorithm (28). In this manner, multiple peaks of fat are included
in the algorithm for accurate spectral
modeling.
Reconstructions were performed
with the same set of acquired complex
data to create four distinct sets of
121
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images per mouse (C.D.G.H., H.Y.; 3
and 8 years of experience, respectively,
in data reconstruction). Data were
reconstructed with and without T2*
correction, and both of these options
were constructed with (multipeak) and
without (single peak) accurate spectral
modeling; the previously described selfcalibrated multipeak IDEAL technique
was used for inclusion of multiple peaks
of fat. The same regions of interest
(ROIs) were chosen for all reconstructions for each mouse.
One potential method to reduce
imaging time is to use a shorter echo
train. A shorter echo train would yield
a shorter repetition time, which is desirable for breath-hold applications;
however, this may reduce the accuracy
of T2* estimation and correction (28).
Previous work has suggested that acquisition of six echoes may provide a
reasonable compromise between accurate T2* correction and imaging time
(27). To investigate this effect as a potential means to reduce imaging time,
data were also reconstructed by using
only the first six acquired echoes (truncating the last nine echoes); the same
four reconstructions and ROI selection
as described for the full 15-echo data
set were performed.
Reconstructions yielded a fat image
(Sf), a water image (Sw), a field map,
and an R2* map. The water and fat
images were used to obtain a fat fraction image (η) on a pixel-by-pixel basis,
as follows:

η

Sf
Sf

Sw

Fat fraction images have the advantage of avoiding B1 coil sensitivity profiles and enabling normalized and useful
quantitative fat measurement (21).

Histologic Assessment
A sample of the left lateral lobe was excised from all mouse livers, fixed in formalin, and stained with hematoxylineosin. Although the liver weights ranged
greatly for all mice because of age and
genotype (average weight, 2.19 g 6
0.88 [standard deviation]), sample sizes
122
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were similar (100–150 mg). Subjective
grading of steatosis was performed
by a surgical pathologist (T.F.W., 36
years of experience) who was blinded
to imaging and lipid extraction results.
Grading results were expressed as the
percentage of cells affected by steatosis
in 5% increments (qualitative histologic
analysis) and additionally according to
Brunt et al (36).
Digitized hematoxylin-eosin–stained
slides were also analyzed with image
analysis software (Image Pro Plus 6.2;
Media Cybernetics, Bethesda, Md) to
obtain a quantitative histologic measurement of steatosis (quantitative histologic
analysis). According to the methods
described in previous reports (13), a
histogram of pixel intensity is generated
from the image. The area above a set
threshold is measured, and the results
are expressed as a fat percentage by
area (13,37,38).

Lipid Extraction
Total hepatic lipid content was determined with a modified Folch extraction
procedure, which used less-toxic organic solvents (39) (C.D.G.H., 6 years
of experience). The liver was separated
into the five major lobes, including the
remaining majority of the left lateral
lobe, and lipids were extracted separately from all lobes. Fat percentage
was expressed as the mass of total lipids recovered in the lobe divided by the
mass of the lobe. The mass fat fractions
from individual lobes were used to calculate a normalized average by weight
of the lobe to report a mass fat fraction
across the entire liver (hereafter, mass
fat fraction).
Imaging Data Analysis
ROI measurements were obtained in the
five major lobes on the fat fraction images (C.D.G.H., 4 years of experience).
Since the lobes ranged greatly in size
and position, ROI size ranged from 6 to
32 mm2. ROIs were chosen to encompass as much of the individual lobe as
possible while attempting to avoid major blood vessels. One ROI was chosen
per lobe. A normalized average by area
of ROI measurement was calculated by
using all lobes to report a fat fraction

percentage across the entire liver (hereafter, imaging fat fraction). ROI measurements were obtained in the same
locations of each mouse for all image
reconstructions. To calculate fat fractions across the entire liver for lipid extraction, a normalized average by mass
of each lobe was calculated by using
mass fat fractions from all five lobes.

Statistical Analyses
All statistical analyses were performed
by using Excel software (version
10.6841.6839 SP3; Microsoft, Redmond,
Wash) with assistance from a statistician with more than 8 years of experience. Linear regression analysis was
performed between average fat fractions
across the entire liver for each imaging
fat fraction reconstruction and average
fat fractions across the entire liver for
qualitative and quantitative histologic
analyses and lipid extraction for every
mouse. Error bars on resulting plots
represent the corresponding measured
standard deviation. Perfect agreement
between imaging fat fraction and another
fat quantification method would have a
slope of 1.0 and an intercept of 0.0.
Two-sided t tests at the .05 significance level were used to determine
whether the estimated slope and intercept were significantly different from
1.0 and 0.0, respectively. To determine
whether significant differences exist between imaging fat fractions and the results
of qualitative and quantitative histologic
analyses and lipid extraction, two-sample
t tests at the .05 significance level were
performed. Bonferroni-adjusted P values
less than .05 indicated significant differences between distributions.
Although a high degree of correlation
and a linear relationship was expected
between the histologic grade and the
imaging fat fraction, a one-to-one relationship between a qualitative technique
and a quantitative technique was not expected. These two techniques involve different methods of fat assessment; while
histologic analysis reports the percentage of cells affected by steatosis, imaging
yields the fat fraction. Thus, a two-sided
t test and a two-sample t test were not
performed against the slopes and distributions, respectively.
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Figure 1

Results

Figure 1: Representative coronal IDEAL water, fat, and fat fraction MR images show the progression of
steatosis in ob/ob mice compared with that in a control ob/+ mouse. Corresponding slides show increasing
macro- and microvesicular steatosis accumulation corresponding to imaging findings. (Hematoxylin-eosin
stain [H&E ]; original magnification, 3100.) T2* correction and accurate spectral modeling were used for
these images. A marked increase in visceral and subcutaneous fat and hepatic steatosis can be seen in the
ob/ob mice compared with the ob/+ mouse, and these features are exaggerated in the 13-week-old ob/
ob mouse compared with the 7-week-old ob/ob mouse. Fat fraction images enable quantification of fat and
enable confirmation of visual suspicion of steatosis: For instance, 0.0% 6 4.5, 14.4% 6 3.9, and 24.7% 6
6.6 fat was measured in the ob/+ mouse, 7-week old ob/ob mouse, and 13-week old ob/ob mouse, respectively. Histologic grading revealed 0%, 50%, and 85% of cells were affected by steatosis in the representative ob/+ mouse, 7-week old ob/ob mouse, and 13-week old ob/ob mouse, respectively.

Radiology: Volume 254: Number 1—January 2010
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Figure 1 shows the progression of steatosis through generated fat, water, and
calculated fat fraction images of a representative control ob/+ mouse and two
ob/ob mice of increasing age. Opposite
the fat fraction images are the corresponding hematoxylin-eosin–slides of
these mice. Histologic grading was consistent with imaging findings; both fat
fraction measurements and histologic
grading scores consistently increase with
age and among ob/ob mice.
Fat fraction measurements from
each reconstruction were plotted against
histologic grades and are shown in
Figure 2, with statistical results summarized in Table 1. Large standard deviations for imaging fat fractions, results
of quantitatitve histologic analysis, and
mass fat fractions are seen for all plots,
which reflect the heterogeneity of fat
deposits across the liver. These plots
show a linear relationship between histologic grading and imaging fat fraction
and may be useful for conversion between imaging and histologic steatosis
assessment. All reconstructions have
intercepts that are not significantly different from 0.0, which indicates that
imaging is sensitive at low fat fractions,
as these two techniques agree particularly well at low fat fractions. For
three mice, estimated fat was not adequately described within the five percentage increments by the pathologist
(66%, 82%, and 68%). These estimates
were included unaltered as points in
Figure 2.
The fat fraction measurements
from each reconstruction were plotted
against the quantitative histologic intensity segmentation technique. These
plots are shown in Figure E1 (online),
and the statistical results are shown
in Table 2. An ambiguity was observed
in the computer segmentation–based
analysis of histologic slides. According
to the pathologist, white areas on the
slides obtained in ob/+ mice were not
fat deposits but corresponded to other
histologic and cellular features that appeared white on hematoxylin-eosin–
stained slides. Although ob/ob slides
also have these features, nonfat white
123
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Figure 2

Figure 2: Graphs show histologic grading results (obtained with qualitative histologic analysis) plotted against imaging fat fraction measurements. (a, b) Single
peak (a) without and (b) with T2* correction. (c, d) Multipeak (c) without and (d) with T2* correction. Statistical parameters are summarized in Table 1. The highest
correlation of determination ( r 2) is seen for the reconstruction with accurate spectral modeling and T2* correction. Intercepts from all methods are not significantly
different from 0.0, indicating all IDEAL correction methods are accurate at low fat fractions. Error bars represent measured standard deviation.

areas are negligible compared with
the large area of confirmed fat vacuoles, which ob/+ mice lack. We concluded that threshold-based segmentation could not be used to distinguish
nonfat white areas from fat vacuoles.
As a result, the intensity segmentation
technique reported fat deposits for
the control mice, which caused the intercepts of these plots to be different
from 0.0. The locations of the intercepts also resulted in increased slope
values, as seen if the control mice
were excluded from linear regression.
However, no points were excluded from
analysis or from the figures.
124

Table 1
Comparison of 15-Echo Fat Fraction Measurements with Qualitative Histologic
Grading
Correction Method
Single peak without
T2* correction
Single peak with
T2* correction
Multipeak without
T2* correction
Multipeak with
T2* correction

r 2 Value

Slope*

Intercept (%)*

P Value†

0.74

0.18 6 0.02 (20.04, 0.04)

0.3 6 1.3 (22.57, 2.57)

.8

0.86

0.21 6 0.02 (20.03, 0.03)

0.71

0.23 6 0.03 (20.05, 0.05)

0.3 6 1.7 (23.45, 3.45)

.9

0.87

0.27 6 0.02 (20.04, 0.04)

21.0 6 1.2 (22.43, 2.43)

.4

20.3 6 1.0 (22.0, 2.0)

.8

* Data are means 6 standard deviations. Data in parentheses are 95% confidence intervals.
†

P value greater than .05 indicates no significant difference between obtained intercept and 0.0.

radiology.rsna.org
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Table 2
Comparison of 15-Echo Fat Fraction Measurements with Quantitative Histologic Grading
Correction Method
Single peak without T2* correction
Single peak with T2* correction
Multipeak without T2* correction
Multipeak with T2* correction

r2 Value

Slope*

P Value†

Intercept (%)*

P Value‡

P Value§

0.74
0.83
0.72
0.82

0.87 6 0.09 (20.18, 0.18)
0.976 0.08 (20.16, 0.16)
1.09 6 0.12 (20.24, 0.24)
1.23 6 0.10 (20.21, 0.21)

.2
.7
.5
.03

24.9 6 1.8 (23.63, 3.63)
26.0 6 1.5 (23.06, 3.06)
26.4 6 2.4 (24.71, 4.71)
27.9 6 2.0 (24.06, 4.06)

.01
.0005
.01
.0005

.0007
.006
.2
.9

* Data are means 6 standard deviations. Data in parentheses are 95% confidence intervals.
†

P . .05 indicates no significant difference between obtained slope and 1.0.

‡

P . .05 indicates no significant difference between obtained intercept and 0.0.

§

P . .05 indicates no significant difference between imaging fat fraction and quantitative histologic fat fractions.

Figure 3 shows the comparison of
all IDEAL reconstructions to lipid extraction mass fat fractions, with statistical results summarized in Table 3.
A bias in the intercepts of the plots of
Figure 3 exists and is likely due to a discrepancy between lipid extraction and
imaging fat fractions; it was expected
that the intercepts of these plots would
be 0.0. Total lipid extractions, such as
the Folch-based methods, are nonspecific and result in the extraction of all
lipids, including those that may be invisible with MR imaging. Conventional MR
proton techniques cannot be used to detect bound or aggregated lipids, such as
those found in lipid membranes or lipoproteins, since these lipids have solidlike
behavior and short T2 values (40–42).
The ob/+ fat fractions are more affected
by MR-invisible lipids than are the ob/
ob fat fractions, given that the latter fat
fractions are dominated by stored triglycerides. As a result of this discrepancy,
nonzero intercepts were generated,
which also increased estimated slope
values and provided an explanation for
errors in the results. For example, if the
ob/+ mice were excluded from linear
regression for the reconstruction with
accurate spectral modeling and T2* correction, near perfect agreement of mass
fat fraction with imaging fat fraction
was seen, and the y intercept increased
to 20.029 6 0.02 (20.063 6 0.01 with
all mice). However, no points were excluded from analysis or figures.
Lower correlation between imaging
fat fractions and all other fat quantification techniques was seen for reconstructions without T2* correction. Fat fracRadiology: Volume 254: Number 1—January 2010
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tions for all compared techniques were
underestimated for reconstructions that
excluded T2* correction, multiple peaks
of fat, or both. Both T2* correction and
multiple peaks of fat must be included
to enable one to accurately quantify fat
in vivo. Further, reconstruction including multiple spectral fat peaks and T2*
correction consistently displays high
correlation with other fat quantification
methods, and no significant differences
between imaging fat fractions and quantitative histologic or lipid extraction
results are seen. Further, imaging fat
fractions with T2* correction displayed
better overall agreement compared with
fat fractions without T2* correction. On
the basis of information from slopes,
intercepts, r2 values, and three P values
of each compared technique, we concluded that the reconstruction, including multiple spectral fat peaks and T2*
correction, was the most accurate reconstruction for fat quantification.
A comparison of fat fraction measurements from data reconstructed
with six and 15 echoes is shown in
Figure E2 (online). These data were
reconstructed using T2* correction and
multiple spectral fat peaks. This plot
demonstrates equivalence between six
echo reconstructions and 15 echo reconstructions, given the high correlation and nearly ideal slope and intercept. In the interest of space, the six
echo plots versus the 15 echo plots for
each reconstruction are not shown, but
they also display equivalence. Linear regression results for each reconstruction
all show excellent correlation with r2
values greater than 0.95.

radiology.rsna.org

Discussion
We have demonstrated close agreement
between MR imaging and three conventional methods for the quantitative
assessment of hepatic steatosis. These
results also demonstrate that corrections for confounding factors of T2* decay, accurate spectral modeling, noise-,
and T1-related bias are necessary for
accurate fat quantification in the liver.
Our results provide validation that MR
imaging enables accurate fat quantification in mice and has potential for use in
the quantitative assessment of hepatic
steatosis in clinical practice.
Previous work in which researchers
compared another modality or technique
with MR imaging often involved the use
of conventional two-point Dixon, spectroscopy, and/or fat or water suppression imaging techniques. The primary
weakness of these methods is that they
do not correct for confounding factors
of T1 and noise biases, T2* decay, or
accurate spectral modeling. In addition,
we performed multiple comparisons
within the same study rather than one
comparison, with emphasis toward the
clinical current standard of qualitative
histologic analysis and lipid extraction
(mass fat fraction). For example, Yokoo
et al (43) and Kim et al (44) addressed
confounding factors and compared
results with spectroscopy only and use
of the two-point Dixon technique for
fat quantification, respectively. To our
knowledge, no other published studies
have addressed all known confounding
factors for accurate fat quantification over
the entire liver and compared imaging fat
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Figure 3

Figure 3: Graphs show lipid extraction mass fat fractions plotted against imaging fat fraction measurements. (a, b) Single peak (a) without and (b) with T2* correction. (c, d) Multipeak (c) without and (d) with T2* correction. Statistical parameters are summarized in Table 3. Dashed lines = line of unity, error bars = measured
standard deviation. All reconstructions showed an intercept that was significantly different from 0.0; however, only reconstructions that included multiple peaks of fat
showed slopes that were not significantly different from 1.0.

fraction with quantitative and qualitative
histologic analysis and lipid extraction.
Our study had several limitations.
First, this technique suffered from a long
imaging time that was necessary to
achieve the spatial resolution and signalto-noise ratio performance needed to
image mice. Clinical implementation
will require a shortened imaging time
with parallel imaging acceleration and
shortened echo train lengths that decrease the repetition time. Second,
although no respiratory artifacts were
encountered, the mice were heavily sedated, and free breathing would likely
be an issue in patients, unless breathhold imaging times could be achieved in
the clinical application of these methods.
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Table 3
Comparison of 15-Echo Fat Fraction Measurements with Lipid Extraction Results
Correction Method
Single peak without
T2* correction
Single peak with
T2* correction
Multipeak without
T2* correction
Multipeak with
T2* correction

r 2 Value

Slope*

0.84

0.79 6 0.06
(20.12, 0.12)
0.87 6 0.05
(20.09, 0.09)
0.99 6 0.08
(20.16, 0.16)
1.11 6 0.06
(20.11, 0.11)

0.92
0.82
0.92

P Value†

Intercept (%)*

P Value‡

P Value§

.002

23.9 6 1.2
(22.47, 2.47)
24.5 6 0.9
(21.86, 1.86)
25.0 6 1.7
(23.33, 3.33)
26.3 6 1.2
(22.34, 2.34)

.004

.001

.00003

.007

.01

.2

.000007

.7

.01
.09
.06

* Data are means 6 standard deviations. Data in parentheses are 95% confidence intervals.
†

P . .05 indicates no significant difference between obtained slope and 1.0.

‡

P . .05 indicates no significant difference between obtained intercept and 0.0.

§

P . .05 indicates no significant difference between imaging fat fraction and mass fat fractions.
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Third, the signal model assumes that
water and fat share the same T2* decay. No methods currently exist with
which to address the potential problem
of differing T2* decays between water
and fat, although this has been recognized (24,27). This potential discrepancy may have introduced bias in our
results, although it is likely that this is
a second-order effect that represents
a minor source of error in comparison
with the effect of other correction factors (shared component of T2* decay,
accurate spectral modeling of fat, T1
bias, and noise-related bias). Future
work will focus on the development of
signal models that allow independent correction of T2* decay for water and fat.
We also investigated the use of
shorter echo trains that are needed to
reduce the repetition time as a means
to reduce examination time to facilitate transition of these findings into
practice, and our results revealed near
equivalence of fat fraction measurements between six- and 15-echo reconstructions. A second way to reduce
examination time is the implementation of parallel imaging with this pulse
sequence. Recent work at our institution has demonstrated the feasibility
of breath-hold imaging in patients with
use of two-dimensional parallel imaging
acceleration (28,45). With the use of
two-dimensional parallel imaging methods to achieve a 22-second breath hold,
we predict that respiratory artifacts will
be largely avoided.
The use of animals in our study
was critical to have large sample sizes
and a true mass fat fraction across the
entire liver, since the entire liver was
harvested and tested. Such testing is
not possible in humans because of the
small size of biopsy samples, and an
animal model enabled abundantly more
extensive and thorough testing than is
allowed in humans. If large volumes of
human tissue are harvested, however,
substantial biohazards may arise; our
laboratory facility was not compatible
with processing human tissue.
Although these methods can be validated in an animal model by using correlation with destructive techniques, such
as histologic analysis and hepatic lipid
Radiology: Volume 254: Number 1—January 2010
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extraction, additional clinical validation is required with a biopsy and imaging correlation study. In addition, the
reproducibility of this method must be
determined before the clinical utility of
these methods can be ascertained. Although unforeseen discrepancies may
arise between these results from mice
to patients, our results have demonstrated the need for correction methods that address confounding factors,
including T2* decay, multiple spectral
peaks of fat, noise bias, and T1-related
bias.
In summary, we have demonstrated
that MR imaging with T2* correction
and accurate spectral modeling correlate strongly with conventional fat
quantification methods. These results
show that MR imaging can be used to
accurately and objectively quantify fat
in vivo and that MR imaging has the
potential to serve as a noninvasive biomarker in the early detection and quantitative assessment of hepatic steatosis.
Acknowledgment: We thank Kazuhiko Shinki,
PhD, for his statistical assistance.
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